WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

BlueWind gets a Category I CPT code for subfascial tibial neuromodulation Emboline runs its first US commercial Emboliner cases at Columbia SedMed raises $4M for a toilet lift that runs without power Surmodics buys Alta Biomed for its PzF coating and a Carlsbad blood loop lab FDA names the first five companies in its READI-Home readmissions program CDRH plans 11 final guidances in FY2027 and puts AI lifecycle management first Edwards wins FDA approval for a pulmonary valve that expands from 13 mm to 22 mm Medtronic wins a Category I CPT code for renal denervation, effective January 2028 Axogen closes the BioCircuit deal and puts $34M of 2027 revenue on NerveTape BlueWind gets a Category I CPT code for subfascial tibial neuromodulation Emboline runs its first US commercial Emboliner cases at Columbia SedMed raises $4M for a toilet lift that runs without power Surmodics buys Alta Biomed for its PzF coating and a Carlsbad blood loop lab FDA names the first five companies in its READI-Home readmissions program CDRH plans 11 final guidances in FY2027 and puts AI lifecycle management first Edwards wins FDA approval for a pulmonary valve that expands from 13 mm to 22 mm Medtronic wins a Category I CPT code for renal denervation, effective January 2028 Axogen closes the BioCircuit deal and puts $34M of 2027 revenue on NerveTape

The Directory / Neurology & Neurotech

Neurology & Neurotech

NeuroSigma

Los Angeles, CA · Unknown · 510(k) cleared

Makes the Monarch eTNS System, an external trigeminal nerve stimulation device worn at night. FDA cleared it as the first non-drug treatment for pediatric ADHD, and cleared a second-generation version in January 2024.

← More Neurology & Neurotech startups

NeuroSigma

COVERAGE